University of Minnesota College of Pharmacy
Dr. Elizabeth Hirsch (@EB_Hirsch) is a tenured Associate Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy. She received B.S. and PharmD (2007) degrees from Creighton University in Omaha, Nebraska. She then completed a PGY1 pharmacy practice residency (2007-2008) and an infectious diseases pharmacotherapy fellowship (2008-2011) at the University of Houston College of Pharmacy and St. Luke’s Episcopal Hospital in Houston, Texas. Dr. Hirsch served as faculty at Northeastern University and Beth Israel Deaconess Medical Center in Boston, Massachusetts, from 2011-2017. She moved her research program to the University of Minnesota College of Pharmacy in 2017. Her research program focuses on the detection and treatment of multidrug-resistant gram-negative infections, with the overall goal of improving the use of antimicrobials for patients with resistant bacterial infections. Her research program has been supported by federal, foundation, and industry sponsors. She has served as an appointed advisor to the CLSI Subcommittee on Antimicrobial Susceptibility Testing since 2017 and is a member of the IDSA 2019 update of the urinary tract infection guidelines expert panel.
Disclosure: Merck: Grant/Research Support; Nabriva Therapeutics: Advisor or Review Panel member
Friday, October 23, 2020
2:45pm – 4:00pm EDT